To determine whether primary cells were similarly sensitive to the combination of a statin and PDE inhibitor, we treated primary AML cells with fluvastatin and/or cilostazol for 48 h, after which apoptosis was quantified by Annexin V staining using flow cytometry. The gene discussed is ANXA5; the disease is acute myeloid leukemia.